Vland Biotech(SH:603739)2020-04-28 16:00Financial Performance - Total revenue for Q1 2020 was RMB 196,422,352.85, representing a 13.23% increase compared to RMB 173,470,991.55 in the same period last year[6] - Net profit attributable to shareholders reached RMB 21,826,805.47, a significant increase of 109.76% from RMB 10,405,521.22 year-on-year[6] - The net profit excluding non-recurring gains and losses was RMB 17,552,107.20, up 329.25% from RMB 4,088,988.77 in the previous year[6] - Basic and diluted earnings per share both stood at RMB 0.14, doubling from RMB 0.07 in the previous year[6] - Net profit for Q1 2020 reached CNY 25,022,767.55, representing a significant increase of 104.3% from CNY 12,251,238.34 in Q1 2019[23] - The company reported a total comprehensive income of CNY 25,138,991.90 for Q1 2020, compared to CNY 11,773,155.88 in Q1 2019, an increase of 113.5%[24] Assets and Liabilities - Total assets at the end of the reporting period were RMB 1,382,342,256.62, a 7.89% increase from RMB 1,281,249,579.06 at the end of the previous year[6] - The company's current assets reached CNY 791,556,108.74, up from CNY 705,905,071.54, indicating an increase of about 12.1%[16] - The total liabilities stood at CNY 327,305,630.66, compared to CNY 248,991,945.00 at the end of 2019, reflecting a rise of approximately 31.4%[18] - Total liabilities as of Q1 2020 amounted to CNY 445,547,493.11, compared to CNY 353,915,510.90 in the previous year, indicating a rise of 26.0%[21] - The company's equity attributable to shareholders reached CNY 984,092,892.28, an increase from CNY 962,184,729.76, reflecting a growth of about 2.9%[18] Cash Flow - Cash flow from operating activities showed a net outflow of RMB -9,357,936.57, an improvement from RMB -23,372,643.57 in the same period last year[6] - The company experienced a net cash outflow from operating activities of CNY -9,357,936.57, an improvement from the previous year's outflow of CNY -23,372,643.57, representing a reduction of about 60%[30] - Investment activities generated a net cash inflow of CNY 8,284,673.56, a significant recovery from a net outflow of CNY -197,173,779.44 in Q1 2019[30] - The cash inflow from financing activities was 179,900,000.00 RMB, while cash outflow for financing activities totaled 103,031,833.54 RMB, resulting in a net cash flow of 76,868,166.46 RMB[34] Expenses - Total operating costs for Q1 2020 were CNY 173,212,986.82, up from CNY 166,237,935.37 in Q1 2019, reflecting a growth of 4.9%[23] - Research and development expenses for Q1 2020 were CNY 15,549,323.01, a decrease of 5.9% from CNY 16,521,013.01 in Q1 2019[23] - The company paid CNY 61,293,943.94 to employees in Q1 2020, a decrease from CNY 63,316,173.02 in Q1 2019, reflecting a reduction of about 3.2%[30] Investments - The company reported a 280.38% increase in investment income, reaching RMB 1,420,057.41 compared to RMB 373,325.84 in the previous year[10] - The company received CNY 181,000,000.00 from other investment activities, which was not reported in the previous year[30] Other Information - The company made a cash donation of RMB 1,000,000 to the Red Cross for pandemic prevention efforts, contributing to a 1092.72% increase in other expenses[10] - The company has implemented new revenue and lease standards starting from 2020, which may impact future financial reporting[34] - The company adopted new revenue and leasing standards effective January 1, 2020, impacting financial reporting[41]